https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
Acute leukemia often comes with life-threatening prognosis outcome and remains a critical clinical issue today. #link# The implementation of measurable residual disease (MRD) using flow cytometry (FC) is highly effective but the interpretation is time-consuming and suffers from physician idiosyncrasy. Recent machine learning algorithms have been proposed to automatically classify acute leukemia samples with and without MRD to address this clinical need. However, most prior works either validate only on a small data cohort or focus on